TABLE 3.
Categorical Distribution of Patient's Global Impression of Improvement Results at the Final Evaluation
Category | Placebo n = 226 | Duloxetine n = 230 | P |
Improved* | 163 (72.1) | 191 (83.0) | 0.0067 |
Unchanged | 59 (26.1) | 34 (14.8) | |
Worsened† | 4 (1.8) | 5 (2.2) |
Data are presented as n (%).
*The “Improved” category included patients who responded “Very much improved”, “Much improved”, or “Minimally improved”.
†The “Worsened” category included patients who responded “Very much worse”, “Much worse”, or “Worse”.